Dx & Vx Co., Ltd. (KOSDAQ:180400)
South Korea · Delayed Price · Currency is KRW 2,330.00
-80.00 (-3.32%)
At close: Jun 19, 2026
Dx & Vx Market Cap
Dx & Vx has a market cap or net worth of 229.34 billion as of June 18, 2026. Its market cap has increased by 113.74% in one year.
Market Cap
229.34B
Enterprise Value
182.20B
Revenue
28.48B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,330.00
Market Cap Chart
Since November 20, 2015, Dx & Vx's market cap has increased from 75.32B to 229.34B, an increase of 204.50%. That is a compound annual growth rate of 11.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 229.34B | 48.39% |
| Dec 30, 2025 | 154.55B | 68.91% |
| Dec 30, 2024 | 91.50B | -48.77% |
| Dec 28, 2023 | 178.59B | 52.96% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 3billion | 213.85B |
| GENINUS | 104.83B |
| Cytogen | 88.59B |
| Inventera | 82.90B |
| GC Medical Science | 74.68B |
| HLB Panagene | 70.48B |
| Protia | 53.45B |
| Seoulin Bioscience | 44.71B |